BioSpace News Archive

SpringWorks Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for nirogacestat, an investigational, oral, small molecule, selective gamma-secretase inhibitor, for the treatment of adult patients with progressive, unresectable, recurrent or refractory desmoid tumors or deep fibromatosis.

French biopharmaceutical company aims to improve data access, quality, and workflow efficiencies

QuestDirect Builds on Quest’s existing consumer offerings available through the new and improved MyQuest patient platform that lets people access their lab results, schedule appointments and pay bills

Lowers 2018 Earnings Guidance

NovaBay® Pharmaceuticals, Inc. announces that it will report third quarter 2018 financial results after market close on Wednesday, November 14.

Management to Host Conference Call at 11:00 a.m. EST

Canadian product revenue increased 27%

Ionis Pharmaceuticals, Inc. today announced that management will present a company overview at the following investor conferences

Maralixibat Phase 2b study interim analysis suggests proof of concept in Alagille syndrome

Compugen Ltd. today reported financial results for the third quarter ended September 30, 2018.